Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 6/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3313017 | 0.81 | EPHX2 (0.36) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL13154396 | 0.77 | EPHX2 (0.44) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL17251906 | 0.75 | NCF1 (0.47) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL3316552 | 0.72 | EPHX2 (0.38) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL5223107 | 0.72 | CASP3 (0.33) | MEN1KMT2A | |
| SCHEMBL17404859 | 0.71 | FAAH (0.44) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL13154401 | 0.70 | EPHX2 (0.39) | EPHX2GPR119FAAHHTR1AALDH1A1 | |
| SCHEMBL2606113 | 0.70 | EPHX2 (0.47) | EPHX2FAAHALDH1A1MEN1KMT2A | |
| SCHEMBL3954923 | 0.70 | ALDH1A1 (0.65) | ALDH1A1MEN1KMT2A | |
| SCHEMBL22991258 | 0.69 | EPHX2 (0.50) | EPHX2FAAHHTR1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100105727-A1 | NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF | DONG-A-PHARM. CO., LTD. (KR) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105727-A1 | NOVEL BENZAMIDE DERIVATIVES AND PROCESS FOR THE PREPARTION THEREOF | HTR4, HTR1A, TPH1 | EPHX2 3996/4885GPR119 297/4885FAAH 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.